Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia

Pietro Pietrini, Alessio Dani, Maura L. Furey, Gene E Alexander, Ulderico Freo, Cheryl L. Grady, Marc J. Mentis, David Mangot, Elliott W. Simon, Barry Horwitz, James V. Haxby, Mark B. Schapiro

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Objective: Down' s syndrome is characterized by the genetically programmed accumulation of substantial Alzheimer's disease neuropathology after age 40 and the development of early dementia years later, providing a unique human model to investigate the preclinical phases of Alzheimer's disease. Older nondemented adults with Down's syndrome show normal rates of regional cerebral glucose metabolism at rest before the onset of dementia, indicating that their neurons maintain function at rest. The authors hypothesized that an audiovisual stimulation paradigm, acting as a stress test, would reveal abnormalities in cerebral glucose metabolism before dementia in the neocortical parietal and temporal areas most vulnerable to Alzheimer' s disease. Method: Regional cerebral glucose metabolism was assessed by means of positron emission tomography (PET) with [18F]fluorodeoxyglucose in eight younger (mean age=35 years, SD=2) and eight older (mean age=50, SD=7) healthy, nondemented adults with trisomy 21 Down's syndrome. PET scans were performed at rest and during audiovisual stimulation in the same scanning session. Levels of general intellectual functioning and compliance were similar in the two groups. Results: At rest the two groups showed no difference in glucose metabolism in any cerebral region. In contrast, during audiovisual stimulation the older subjects with Down' s syndrome had significantly lower glucose metabolic rates in the parietal and temporal cortical areas. Conclusions: Abnormalities in cerebral metabolism during stimulation appeared in the first cortical regions typically affected in Alzheimer's disease. These results indicate that a stress test paradigm can detect metabolic abnormalities in the preclinical stages of Alzheimer's disease despite normal cerebral metabolism at rest.

Original languageEnglish (US)
Pages (from-to)1063-1069
Number of pages7
JournalAmerican Journal of Psychiatry
Volume154
Issue number8
StatePublished - Aug 1997
Externally publishedYes

Fingerprint

Down Syndrome
Dementia
Alzheimer Disease
Glucose
Brain
Exercise Test
Positron-Emission Tomography
Fluorodeoxyglucose F18
Compliance
Neurons

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia. / Pietrini, Pietro; Dani, Alessio; Furey, Maura L.; Alexander, Gene E; Freo, Ulderico; Grady, Cheryl L.; Mentis, Marc J.; Mangot, David; Simon, Elliott W.; Horwitz, Barry; Haxby, James V.; Schapiro, Mark B.

In: American Journal of Psychiatry, Vol. 154, No. 8, 08.1997, p. 1063-1069.

Research output: Contribution to journalArticle

Pietrini, P, Dani, A, Furey, ML, Alexander, GE, Freo, U, Grady, CL, Mentis, MJ, Mangot, D, Simon, EW, Horwitz, B, Haxby, JV & Schapiro, MB 1997, 'Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia', American Journal of Psychiatry, vol. 154, no. 8, pp. 1063-1069.
Pietrini, Pietro ; Dani, Alessio ; Furey, Maura L. ; Alexander, Gene E ; Freo, Ulderico ; Grady, Cheryl L. ; Mentis, Marc J. ; Mangot, David ; Simon, Elliott W. ; Horwitz, Barry ; Haxby, James V. ; Schapiro, Mark B. / Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia. In: American Journal of Psychiatry. 1997 ; Vol. 154, No. 8. pp. 1063-1069.
@article{84edfd9469d1491bbc50c2acf6c2364e,
title = "Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia",
abstract = "Objective: Down' s syndrome is characterized by the genetically programmed accumulation of substantial Alzheimer's disease neuropathology after age 40 and the development of early dementia years later, providing a unique human model to investigate the preclinical phases of Alzheimer's disease. Older nondemented adults with Down's syndrome show normal rates of regional cerebral glucose metabolism at rest before the onset of dementia, indicating that their neurons maintain function at rest. The authors hypothesized that an audiovisual stimulation paradigm, acting as a stress test, would reveal abnormalities in cerebral glucose metabolism before dementia in the neocortical parietal and temporal areas most vulnerable to Alzheimer' s disease. Method: Regional cerebral glucose metabolism was assessed by means of positron emission tomography (PET) with [18F]fluorodeoxyglucose in eight younger (mean age=35 years, SD=2) and eight older (mean age=50, SD=7) healthy, nondemented adults with trisomy 21 Down's syndrome. PET scans were performed at rest and during audiovisual stimulation in the same scanning session. Levels of general intellectual functioning and compliance were similar in the two groups. Results: At rest the two groups showed no difference in glucose metabolism in any cerebral region. In contrast, during audiovisual stimulation the older subjects with Down' s syndrome had significantly lower glucose metabolic rates in the parietal and temporal cortical areas. Conclusions: Abnormalities in cerebral metabolism during stimulation appeared in the first cortical regions typically affected in Alzheimer's disease. These results indicate that a stress test paradigm can detect metabolic abnormalities in the preclinical stages of Alzheimer's disease despite normal cerebral metabolism at rest.",
author = "Pietro Pietrini and Alessio Dani and Furey, {Maura L.} and Alexander, {Gene E} and Ulderico Freo and Grady, {Cheryl L.} and Mentis, {Marc J.} and David Mangot and Simon, {Elliott W.} and Barry Horwitz and Haxby, {James V.} and Schapiro, {Mark B.}",
year = "1997",
month = "8",
language = "English (US)",
volume = "154",
pages = "1063--1069",
journal = "American Journal of Psychiatry",
issn = "0002-953X",
publisher = "American Psychiatric Association",
number = "8",

}

TY - JOUR

T1 - Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia

AU - Pietrini, Pietro

AU - Dani, Alessio

AU - Furey, Maura L.

AU - Alexander, Gene E

AU - Freo, Ulderico

AU - Grady, Cheryl L.

AU - Mentis, Marc J.

AU - Mangot, David

AU - Simon, Elliott W.

AU - Horwitz, Barry

AU - Haxby, James V.

AU - Schapiro, Mark B.

PY - 1997/8

Y1 - 1997/8

N2 - Objective: Down' s syndrome is characterized by the genetically programmed accumulation of substantial Alzheimer's disease neuropathology after age 40 and the development of early dementia years later, providing a unique human model to investigate the preclinical phases of Alzheimer's disease. Older nondemented adults with Down's syndrome show normal rates of regional cerebral glucose metabolism at rest before the onset of dementia, indicating that their neurons maintain function at rest. The authors hypothesized that an audiovisual stimulation paradigm, acting as a stress test, would reveal abnormalities in cerebral glucose metabolism before dementia in the neocortical parietal and temporal areas most vulnerable to Alzheimer' s disease. Method: Regional cerebral glucose metabolism was assessed by means of positron emission tomography (PET) with [18F]fluorodeoxyglucose in eight younger (mean age=35 years, SD=2) and eight older (mean age=50, SD=7) healthy, nondemented adults with trisomy 21 Down's syndrome. PET scans were performed at rest and during audiovisual stimulation in the same scanning session. Levels of general intellectual functioning and compliance were similar in the two groups. Results: At rest the two groups showed no difference in glucose metabolism in any cerebral region. In contrast, during audiovisual stimulation the older subjects with Down' s syndrome had significantly lower glucose metabolic rates in the parietal and temporal cortical areas. Conclusions: Abnormalities in cerebral metabolism during stimulation appeared in the first cortical regions typically affected in Alzheimer's disease. These results indicate that a stress test paradigm can detect metabolic abnormalities in the preclinical stages of Alzheimer's disease despite normal cerebral metabolism at rest.

AB - Objective: Down' s syndrome is characterized by the genetically programmed accumulation of substantial Alzheimer's disease neuropathology after age 40 and the development of early dementia years later, providing a unique human model to investigate the preclinical phases of Alzheimer's disease. Older nondemented adults with Down's syndrome show normal rates of regional cerebral glucose metabolism at rest before the onset of dementia, indicating that their neurons maintain function at rest. The authors hypothesized that an audiovisual stimulation paradigm, acting as a stress test, would reveal abnormalities in cerebral glucose metabolism before dementia in the neocortical parietal and temporal areas most vulnerable to Alzheimer' s disease. Method: Regional cerebral glucose metabolism was assessed by means of positron emission tomography (PET) with [18F]fluorodeoxyglucose in eight younger (mean age=35 years, SD=2) and eight older (mean age=50, SD=7) healthy, nondemented adults with trisomy 21 Down's syndrome. PET scans were performed at rest and during audiovisual stimulation in the same scanning session. Levels of general intellectual functioning and compliance were similar in the two groups. Results: At rest the two groups showed no difference in glucose metabolism in any cerebral region. In contrast, during audiovisual stimulation the older subjects with Down' s syndrome had significantly lower glucose metabolic rates in the parietal and temporal cortical areas. Conclusions: Abnormalities in cerebral metabolism during stimulation appeared in the first cortical regions typically affected in Alzheimer's disease. These results indicate that a stress test paradigm can detect metabolic abnormalities in the preclinical stages of Alzheimer's disease despite normal cerebral metabolism at rest.

UR - http://www.scopus.com/inward/record.url?scp=0030753975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030753975&partnerID=8YFLogxK

M3 - Article

C2 - 9247390

AN - SCOPUS:0030753975

VL - 154

SP - 1063

EP - 1069

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

SN - 0002-953X

IS - 8

ER -